Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 4, keine Gesamtzahl für „presented“
Suchtreffer
Begriffe & Kennungen
Bronchitol · 4.8 · Within each frequency grouping, adverse reactions are presented in order of decreasing seriousness.
Eintrag öffnenBuccolam · 4.8 · Within each frequency grouping, adverse reactions are presented in order of decreasing seriousness:
Eintrag öffnenBusulfan Fresenius Kabi · 4.8 · Busulfan in combination with fludarabine (FB) The incidence of each adverse reactions presented in the followi
Eintrag öffnenBysumlog · 4.8 · Within each frequency grouping, adverse reactions are presented in order of decreasing seriousness.
Eintrag öffnenCabazitaxel Accord · 4.8 · The incidences from the pooled analysis of these 3 trials are presented below and in the tabulated list. The m
Eintrag öffnenCibinqo · 4.8 · Listed in Table 2 are adverse reactions observed in atopic dermatitis clinical studies presented by system org
Eintrag öffnenCircadin · 4.8 · 4 Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness.
Eintrag öffnenClopidogrel Krka d.d. (previously Zopya) · 4.8 · 9 Within each system organ class, adverse reactions are presented in order of decreasing seriousness.
Eintrag öffnenCopalia HCT · 4.8 · The safety profile of Copalia HCT presented below is based on clinical studies performed with Copalia HCT and
Eintrag öffnenCresemba · 4.8 · Within each frequency grouping, adverse reactions are presented in order of decreasing seriousness.
Eintrag öffnenCresemba · 4.8 · Within each frequency grouping, adverse reactions are presented in order of decreasing seriousness.
Eintrag öffnenCrysvita · 4.8 · The adverse reactions are presented by system organ class and frequency categories, defined using the followin
Eintrag öffnenCubicin · 4.8 · Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness.
Eintrag öffnenCymbalta · 4.8 · Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness.
Eintrag öffnenCyramza · 4.8 · 12 Within each frequency grouping, ADRs are presented in order of decreasing seriousness.
Eintrag öffnenDafiro HCT · 4.8 · The safety profile of Dafiro HCT presented below is based on clinical studies performed with Dafiro HCT and th
Eintrag öffnenDarunavir Viatris (previously Darunavir Mylan) · 4.5 · 49 OATP1B1 and OATP1B3 (see contraindications and recommendations presented in the section above). Cobicistat
Eintrag öffnenDatroway · 4.8 · 8 be estimated from the available data). Within each frequency grouping, adverse reactions are presented in th
Eintrag öffnenDaxas · 4.8 · Within each frequency grouping, adverse reactions are presented in order of decreasing seriousness.
Eintrag öffnenDaxas · 4.8 · Within each frequency grouping, adverse reactions are presented in order of decreasing seriousness.
Eintrag öffnen